enliGHten: A Multicenter, Phase 3, Long-term, Open-label Trial Investigating Safety and Efficacy of TransCon hGH Administered Once-Weekly in Children with Growth Hormone Deficiency (GHD) Who Have Completed a Prior TransCon hGH Clinical Trial

  • Bergman, Philip (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date23/02/21 → 22/02/26

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • treatment safety